|Phase of Study:||Phase III|
|Treatment Location:||Both at MDACC & outside MDACC at one or more Collaborating Sites or Institutions|
|Estimated Length of Stay in Houston:||Not applicable|
|Supported By:||PharmaMar S.A.|
|Return Visit:||Screening visit, treatment every three weeks in both arms. Labwork on day 1,8 |
and 15 of each cycle. End of treatment visit.
|Home Care:||Patients can receive supportive care during the trial.|